PMP22 and chronic inflammatory demyelinating polyradiculoneuropathy: Interestingly, it was newly classified as an autoimmune nodopathy in the recent update of the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) CIDP guidelines, and not as a CIDP variant, because of its different clinical and pathological characteristics and response to CIDP treatment (10).